Enhanced vincristine neurotoxicity from drug interactions: Case report and review of literature

被引:46
作者
Sathiapalan, RK [1 ]
El-Solh, H [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Sect Pediat Hematol Oncol, Riyadh 11211, Saudi Arabia
关键词
drug interaction; toxicity; vincristine;
D O I
10.1080/088800101753328529
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study reports observed toxicity in a child with acute lymphocytic leukemia who had received vincristine (VCR) with nifedipine and itraconazole. A 5-year-old child with leukemia developed bilateral cranial nerve palsies, severe peripheral neuropathy involving upper and lower extremities, seizures, hypertension, heart failure, and syndrome of inappropriate antidiuretic hormone secretion after being treated with VCR, nifedipine, rind itraconazole. Appropriate management of the above problems including discontinuation of VCR resulted in recovery from neurotoxic manifestations. Concurrent administration of VCR with nifedipine and itraconazole may enhance its neurotoxicity.
引用
收藏
页码:543 / 546
页数:4
相关论文
共 12 条
  • [1] Bohme A, 1995, ANN HEMATOL, V71, P311, DOI 10.1007/BF01697985
  • [2] Chan JD, 1998, PHARMACOTHERAPY, V18, P1304
  • [3] FEDELI L, 1989, CANCER, V64, P1805, DOI 10.1002/1097-0142(19891101)64:9<1805::AID-CNCR2820640908>3.0.CO
  • [4] 2-D
  • [5] Severe vincristine toxicity in combination with itraconazole
    Gillies, J
    Hung, KA
    Fitzsimons, E
    Soutar, R
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 1998, 20 (02): : 123 - 124
  • [6] AMELIORATION OF VINCRISTINE NEUROTOXICITY BY GLUTAMIC-ACID
    JACKSON, DV
    WELLS, HB
    ATKINS, JN
    ZEKAN, PJ
    WHITE, DR
    RICHARDS, F
    CRUZ, JM
    MUSS, HB
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 84 (06) : 1016 - 1022
  • [7] JACKSON DV, 1986, CANCER CHEMOTH PHARM, V17, P281
  • [8] CLINICAL-TRIAL OF PYRIDOXINE TO REDUCE VINCRISTINE NEUROTOXICITY
    JACKSON, DV
    POPE, EK
    MCMAHAN, RA
    COOPER, MR
    ATKINS, JN
    CALLAHAN, RD
    PASCHOLD, EH
    GRIMM, RA
    HOPKINS, JO
    MUSS, HB
    RICHARDS, F
    STUART, JJ
    WHITE, DR
    ZEKAN, PJ
    CRUZ, JM
    SPURR, CL
    CAPIZZI, RL
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1986, 4 (01) : 37 - 41
  • [9] Jeng M, 1999, J PEDIAT HEMATOL ONC, V21, P329
  • [10] The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: Implications for drug interactions
    Kivisto, KT
    Kroemer, HK
    Eichelbaum, M
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (06) : 523 - 530